-
[YEAR:13-1-2005]Kim,D., Wang,L., Beconi,M., Eiermann,G.J., Fisher,M.H., He,H., Hickey,G.J., Kowalchick,J.E., Leiting,B., Lyons,K., Marsilio,F., McCann,M.E., Patel,R.A., Petrov,A., Scapin,G., Patel,S.B., Roy,R.S., Wu,J.K., Wyvratt,M.J., Zhang,B.B., Zhu,L., Thornberry,N.A. and Weber,A.E.
(2R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin -7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
J Med Chem (13-1-2005) 48, 141-151. PubMed Europe PubMed DOI I
2005
